We are live on ! Find out more
BNR

Burning Rock Biotech

18 hedge funds and large institutions have $9.65M invested in Burning Rock Biotech in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 8 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0.26% less ownership

Funds ownership: 2.85%2.59% (-0.26%)

14% less funds holding

Funds holding: 2118 (-3)

39% less capital invested

Capital invested by funds: $15.8M → $9.65M (-$6.19M)

88% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 8

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
18
Holders Change
-3
Holders Change %
-14.29%
% of All Funds
0.24%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
Increased
1
Reduced
8
Closed
3
Calls
Puts
Net Calls
Net Calls Change

BNR Hedge Fund Activity: Q1 2025 in Review

18 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Burning Rock Biotech (BNR) for Q1 2025, worth a combined $9.65M — down 39% from $15.8M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of BNR and 0 opened new positions — a net loss of 3 holders — while 8 trimmed existing stakes and 1 added.

The largest buyer was BlackRock, adding an estimated $25. The largest seller was CRCM LP, cutting an estimated $622K.

  • 18 institutional investors held Burning Rock Biotech (BNR) as of Q1 2025, down from 21 in Q4 2024.
  • Funds reported $9.65M of Burning Rock Biotech stock for Q1 2025, down 39% quarter-over-quarter.
  • 0 funds opened new Burning Rock Biotech positions in Q1 2025 and 3 closed out, a net change of -3 holders.
  • The largest Burning Rock Biotech buyer in Q1 2025 was BlackRock, an estimated $25 added.
  • The largest Burning Rock Biotech seller in Q1 2025 was CRCM LP, an estimated $622K sold.

Based on aggregated 13F filings for Q1 2025.